TEDCO announced a Pre-Seed Builder Fund investment in NanoBioFAB. The Pre-Seed Builder Fund invests in and provides executive support to Maryland-based technology companies run by entrepreneurs who demonstrate economic disadvantage.
TEDCO announces the selection of AIN Ventures as one of the early-stage venture capital fund managers supporting the management and investment of up to $10 million in U.S. Department of Treasury State Small Business Credit Initiative (SSBCI) funding.
TEDCO, Maryland’s economic engine for technology companies, announced a recent Pre-Seed Builder Fund investment in Sybal. This Maryland-based software startup provides computational governance solutions designed to support various industries.
TEDCO, Maryland’s economic engine for technology companies, announced a recent State Small Business Credit Initiative (SSBCI) investment in Sonavex. TEDCO’s SSBCI funds were provided after the State of Maryland chose TEDCO to be one of the various stewards of this essential funding, allowing for more investments in target communities and areas with small, micro and Socially and Economically Disadvantaged Individual (SEDI) businesses.
“At PerSoN, we are looking to revolutionize the healthcare industry by offering more personalized and accessible care,” said Sarah Iranpour, CEO of PerSoN. “With this most recent investment from TEDCO, we are looking forward to continuing research and development towards creating groundbreaking care for patients with chronic conditions.”
TEDCO, Maryland’s economic engine for technology companies, announced a recent Builder Fund investment in JuneBrain Inc., a biotechnology company. TEDCO’s Pre-Seed Builder Fund is part of TEDCO’s Social Impact Funds, which were created to engage and invest in economically underserved founders and communities.
“Simmbion’s innovative thinking could allow for continued advancement in the creation of synthetic cell technology and biologics,” said Jean-Luc Park, senior director of Social Impact Funds. “We look forward to seeing how their research and development support the continued growth of Maryland’s ecosystem and would like to extend the invitation to other technology start-ups from all industries to apply for TEDCO’s Funds.”
“Our proprietary approach standardizes the tissue diagnostic process using contemporary spatial biology-enabling platforms,” said Paul Aiyetan, founder, CEO and director of NEOPATHOLOGY CORP. “Through this process, we are hoping to reduce diagnostic errors, improve diagnostic accuracy and expedite the time to treatment initiation. Thanks to TEDCO’s investment, we can continue progressing towards our goals.”
Revelo has developed a suite of products designed to capture, analyze and report on multiple metrics from various sources. With data collection, data analysis and data reporting capabilities, the Revelo integrates with several commercial business intelligence dashboards as well as open-source software. Their solution aims to offer flexible features at cost-efficient prices.
TEDCO, Maryland’s economic engine for technology companies, announced a recent round of investments through its Maryland Innovation Initiative (MII), marking a significant milestone in promoting the commercialization of groundbreaking research from Maryland's prestigious academic institutions.